Effects of fibrin-binding oligopeptide on osteopromotion in rabbit calvarial defects

Journal of Periodontal and Implant Science

Volumn 40, Issue 5, 2010, Pages 211-219

  Lee, Ju A ^a   Ku, Young ^a   Rhyu, In Chul ^a   Chung, Chong Pyoung ^a   Park, Yoon Jeong ^a  

^a BK 21 Plus   (South Korea)

Author keywords

Fibrin; Fibronectins; Oligopeptides

Indexed keywords

EID: 84859780125     PISSN: 20932278     EISSN: 20932286     Source Type: Journal    
DOI: 10.5051/jpis.2010.40.5.211     Document Type: Article

References (45)

1. Hallman M, Cederlund A, Lindskog S, Lundgren S, Sennerby L. A clinical histologic study of bovine hydroxyapatite in combination with autogenous bone and fibrin glue for maxillary sinus floor augmentation. Results after 6 to 8 months of healing. Clin Oral Implants Res 2001;12:135-43.
2. Carlson ER, Marx RE. Part II. Mandibular reconstruction using cancellous cellular bone grafts. J Oral Maxillofac Surg 1996;54:889-97.
3. Petrovic L, Schlegel AK, Schultze-Mosgau S, Wiltfang J. Different substitute biomaterials as potential scaffolds in tissue engineering. Int J Oral Maxillofac Implants 2006; 21:225-31.
4. Springer IN, Terheyden H, Geiss S, Harle F, Hedderich J, Acil Y. Particulated bone grafts: effectiveness of bone cell supply. Clin Oral Implants Res 2004;15:205-12.
5. Garrett S. Periodontal regeneration around natural teeth. Ann Periodontol 1996;1:621-66.
6. Jensen SS, Aaboe M, Pinholt EM, Hjorting-Hansen E, Melsen F, Ruyter IE. Tissue reaction and material characteristics of four bone substitutes. Int J Oral Maxillofac Implants 1996;11:55-66.
7. Fukuta K, Har-Shai Y, Collares MV, Lichten JB, Jackson IT. Comparison of inorganic bovine bone mineral particles with porous hydroxyapatite granules and cranial bone dust in the reconstruction of full-thickness skull defect. J Craniofac Surg 1992;3:25-9.
8. Haas R, Donath K, Fodinger M, Watzek G. Bovine hydroxyapatite for maxillary sinus grafting: comparative histomorphometric findings in sheep. Clin Oral Implants Res 1998; 9:107-16.
9. Kasabah S, Simunek A, Krug J, Lecaro MC. Maxillary sinus augmentation with deproteinized bovine bone (Bio-Oss) and Impladent dental implant system. Part II. Evaluation of deprotienized bovine bone (Bio-Oss) and implant surface. Acta Medica (Hradec Kralove) 2002;45:167-71.
10. Maiorana C, Redemagni M, Rabagliati M, Salina S. Treatment of maxillary ridge resorption by sinus augmentation with iliac cancellous bone, anorganic bovine bone, and endosseous implants: a clinical and histologic report. Int J Oral Maxillofac Implants 2000;15:873-8.
11. Merkx MA, Maltha JC, Freihofer HP. Incorporation of composite bone implants in the facial skeleton. Clin Oral Implants Res 2000;11:422-9.
12. Schwartz Z, Weesner T, van Dijk S, Cochran DL, Mellonig JT, Lohmann CH, et al. Ability of deproteinized cancellous bovine bone to induce new bone formation. J Periodontol 2000;71:1258-69.
13. Barboza EP, Duarte ME, Geolas L, Sorensen RG, Riedel GE, Wikesjo UM. Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog. J Periodontol 2000;71:488-96.
14. Rocchietta I, Dellavia C, Nevins M, Simion M. Bone regenerated via rhPDGF-bB and a deproteinized bovine bone matrix: backscattered electron microscopic element analysis. Int J Periodontics Restorative Dent 2007;27:539-45.
15. Grzesik WJ, Ivanov B, Robey FA, Southerland J, Yamauchi M. Synthetic integrin-binding peptides promote adhesion and proliferation of human periodontal ligament cells in vitro. J Dent Res 1998;77:1606-12.
16. Kantlehner M, Schaffner P, Finsinger D, Meyer J, Jonczyk A, Diefenbach B, et al. Surface coating with cyclic RGD peptides stimulates osteoblast adhesion and proliferation as well as bone formation. Chembiochem 2000;1:107-14.
17. Mosher DF. Fibronectin. San Diego: Academic Press; 1989.
18. Magnusson MK, Mosher DF. Fibronectin: structure, assembly, and cardiovascular implications. Arterioscler Thromb Vasc Biol 1998;18:1363-70.
19. Corbett SA, Lee L, Wilson CL, Schwarzbauer JE. Covalent cross-linking of fibronectin to fibrin is required for maximal cell adhesion to a fibronectin-fibrin matrix. J Biol Chem 1997;272:24999-5005.
20. Grinnell F, Feld M, Minter D. Fibroblast adhesion to fibrinogen and fibrin substrata: requirement for cold-insoluble globulin (plasma fibronectin). Cell 1980;19:517-25.
21. Corbett SA, Wilson CL, Schwarzbauer JE. Changes in cell spreading and cytoskeletal organization are induced by adhesion to a fibronectin-fibrin matrix. Blood 1996;88: 158-66.
22. Greiling D, Clark RA. Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. J Cell Sci 1997;110:861-70.
23. Mosher DF, Schad PE, Kleinman HK. Inhibition of blood coagulation factor XIIIa-mediated cross-linking between fibronectin and collagen by polyamines. J Supramol Struct 1979;11:227-35.
24. Damsky CH. Extracellular matrix-integrin interactions in osteoblast function and tissue remodeling. Bone 1999;25: 95-6.
25. Okazaki K, Shimizu Y, Xu H, Ooya K. Blood-filled spaces with and without deproteinized bone grafts in guided bone regeneration. A histomorphometric study of the rabbit skull using non-resorbable membrane. Clin Oral Implants Res 2005;16:236-43.
26. Camargo PM, Wolinsky LE, Ducar JP, Lagos R, Pirih FQ, Jeffcoat M, et al. The effect of fibronectin and a bone xenograft on regenerative treatment: a feasibility study. Compend Contin Educ Dent 2006;27:560-8.
27. Lekovic V, Camargo PM, Weinlaender M, Vasilic N, Djordjevic M, Kenney EB. The use of bovine porous bone mineral in combination with enamel matrix proteins or with an autologous fibrinogen/fibronectin system in the treatment of intrabony periodontal defects in humans. J Periodontol 2001;72:1157-63.
28. Di Bella C, Farlie P, Penington AJ. Bone regeneration in a rabbit critical-sized skull defect using autologous adiposederived cells. Tissue Eng Part A 2008;14:483-90.
29. Schonmeyr BH, Wong AK, Li S, Gewalli F, Cordiero PG, Mehrara BJ. Treatment of hydroxyapatite scaffolds with fibronectin and fetal calf serum increases osteoblast adhesion and proliferation in vitro. Plast Reconstr Surg 2008; 121:751-62.
30. Lee JA, Ku Y, Park YJ, Koo KT, Kim TI, Seol YJ, et al. The biologic effect of fibrin-binding synthetic oligopeptide on periodontal ligament cells. J Korean Acad Periodontol 2009;39:45-52.
31. Terheyden H, Jepsen S, Moller B, Tucker MM, Rueger DC. Sinus floor augmentation with simultaneous placement of dental implants using a combination of deproteinized bone xenografts and recombinant human osteogenic protein-1. A histometric study in miniature pigs. Clin Oral Implants Res 1999;10:510-21.
32. Park JB, Lee JY, Park HN, Seol YJ, Park YJ, Rhee SH, et al. Osteopromotion with synthetic oligopeptide-coated bovine bone mineral in vivo. J Periodontol 2007;78:157-63.
33. Gordjestani M, Dermaut L, De Ridder L, De Waele P, De Leersnijder W, Bosman F. Osteopontin and bone metabolism in healing cranial defects in rabbits. Int J Oral Maxillofac Surg 2006;35:1127-32.
34. Schmitz JP, Hollinger JO. The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res 1986;205:299-308.
35. Frame JW. A convenient animal model for testing bone substitute materials. J Oral Surg 1980;38:176-80.
36. Hollinger JO, Kleinschmidt JC. The critical size defect as an experimental model to test bone repair materials. J Craniofac Surg 1990;1:60-8.
37. Ascherman JA, Foo R, Nanda D, Parisien M. Reconstruction of cranial bone defects using a quick-setting hydroxyapatite cement and absorbable plates. J Craniofac Surg 2008;19:1131-5.
38. Pripatnanont P, Nuntanaranont T, Vongvatcharanon S, Limlertmongkol S. Osteoconductive effects of 3 heattreated hydroxyapatites in rabbit calvarial defects. J Oral Maxillofac Surg 2007;65:2418-24.
39. McAllister BS, Margolin MD, Cogan AG, Buck D, Hollinger JO, Lynch SE. Eighteen-month radiographic and histologic evaluation of sinus grafting with anorganic bovine bone in the chimpanzee. Int J Oral Maxillofac Implants 1999;14: 361-8.
40. Klinge B, Alberius P, Isaksson S, Jonsson J. Osseous response to implanted natural bone mineral and synthetic hydroxylapatite ceramic in the repair of experimental skull bone defects. J Oral Maxillofac Surg 1992;50:241-9.
41. Schlegel AK. Bio-Oss bone replacement material. Longterm results with Bio-Oss bone replacement material. Schweiz Monatsschr Zahnmed 1996;106:141-9.
42. Skoglund A, Hising P, Young C. A clinical and histologic examination in humans of the osseous response to implanted natural bone mineral. Int J Oral Maxillofac Implants 1997;12:194-9.
43. Yildirim M, Spiekermann H, Handt S, Edelhoff D. Maxillary sinus augmentation with the xenograft Bio-Oss and autogenous intraoral bone for qualitative improvement of the implant site: a histologic and histomorphometric clinical study in humans. Int J Oral Maxillofac Implants 2001;16:23-33.
44. Pierschbacher MD, Ruoslahti E. Variants of the cell recognition site of fibronectin that retain attachment-promoting activity. Proc Natl Acad Sci U S A 1984;81:5985-8.
45. Rooney MM, Farrell DH, van Hemel BM, de Groot PG, Lord ST. The contribution of the three hypothesized integrin-binding sites in fibrinogen to platelet-mediated clot retraction. Blood 1998;92:2374-81.